Minimizing dynamic knee spacer complications in infected revision arthroplasty

Clinical Orthopaedics and Related Research

Volumn 470, Issue 1, 2012, Pages 220-227

  Johnson, Aaron J ^a   Sayeed, Siraj A ^a   Naziri, Qais ^a   Khanuja, Harpal S ^a   Mont, Michael A ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CEMENT SPACER; CONFERENCE PAPER; DEVICE INFECTION; DYNAMIC SPACER COMPLICATION; FEMALE; HUMAN; KNEE SOCIETY SCORE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANGE OF MOTION; REIMPLANTATION; REINFECTION; RETROSPECTIVE STUDY; TOTAL KNEE REPLACEMENT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONVALESCENCE; FOLLOW UP; INFECTION; INSTRUMENTATION; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE ARTHROPLASTY; KNEE PROSTHESIS; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PAIN; PROSTHESIS; RADIOGRAPHY; REOPERATION; RISK ASSESSMENT; TREATMENT OUTCOME;

AGED; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84865098076     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-2095-4     Document Type: Conference Paper

References (55)

1. Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23:1232-1238.
2. Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop Relat Res. 2002;401:230-238.
3. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010; 468:45-51.
4. Bradbury T, Fehring TK, Taunton M, Hanssen A, Azzam K, Parvizi J, Odum SM. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty. 2009;24:101-104.
5. Brown AR, Taylor GJ, Gregg PJ. Air contamination during skin preparation and draping in joint replacement surgery. J Bone Joint Surg Br. 1996;78:92-94.
6. Buechel FF Sr. Long-term followup after mobile-bearing total knee replacement. Clin Orthop Relat Res. 2002;404:40-50.
7. Della Valle CJ, Bogner E, Desai P, Lonner JH, Adler E, Zuckerman JD, Di Cesare PE. Analysis of frozen sections of intraoperative specimens obtained at the time of reoperation after hip or knee resection arthroplasty for the treatment of infection. J Bone Joint Surg Am. 1999;81:684-689.
8. Della Valle CJ, Sporer SM, Jacobs JJ, Berger RA, Rosenberg AG, Paprosky WG. Preoperative testing for sepsis before revision total knee arthroplasty. J Arthroplasty. 2007;22:90-93.
9. Der Tavitian J, Ong SM, Taub NA, Taylor GJ. Body-exhaust suit versus occlusive clothing: a randomised, prospective trial using air and wound bacterial counts. J Bone Joint Surg Br. 2003;85: 490-494.
10. Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs. 2009;28:141-145.
11. Emerson RH Jr., Muncie M, Tarbox TR, Higgins LL. Comparison of a static with a mobile spacer in total knee infection. Clin Orthop Relat Res. 2002;404:132-138.
12. Engh GA, Ammeen DJ. Bone loss with revision total knee arthroplasty: defect classification and alternatives for reconstruction. Instr Course Lect. 1999;48:167-175.
13. Evans RP. Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res. 2004;427:37-46.
14. Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis. The Ranawat Award. Clin Orthop Relat Res. 2000;380:9-16.
15. Freeman MG, Fehring TK, Odum SM, Fehring K, Griffin WL, Mason JB. Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty. 2007;22:1116-1121.
16. Gacon G, Laurencon M, Van de Velde D, Giudicelli DP. [Two stages reimplantation for infection after knee arthroplasty: apropos of a series of 29 cases] [in French]. Rev Chir Orthop Reparatrice Appar Mot. 1997;83:313-323.
17. Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009;467:1699-1705.
18. Goksan SB, Freeman MA. One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br. 1992;74:78-82.
19. Haddad FS, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP. The PROSTALAC functional spacer in twostage revision for infected knee replacements: prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br. 2000;82: 807-812.
20. Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35-39.
21. Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13:22-28.
22. Hofmann AA, Goldberg T, Tanner AM, Kurtin SM. Treatment of infected total knee arthroplasty using an articulating spacer: 2-to 12-year experience. Clin Orthop Relat Res. 2005;430:125-131.
23. Hsu YC, Cheng HC, Ng TP, Chiu KY. Antibiotic-loaded cement articulating spacer for 2-stage reimplantation in infected total knee arthroplasty: a simple and economic method. J Arthroplasty. 2007;22:1060-1066.
24. Incavo SJ, Russell RD, Mathis KB, Adams H. Initial results of managing severe bone loss in infected total joint arthroplasty using customized articulating spacers. J Arthroplasty. 2009;24: 607-613.
25. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248: 13-14.
26. Keating EM, Meding JB, Faris PM, Ritter MA. Long-term followup of nonmodular total knee replacements. Clin Orthop Relat Res. 2002;404:34-39.
27. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty. 1999;14:339-346.
28. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89: 780-785.
29. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984-991.
30. Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:52-56.
31. Lachiewicz PF, Falatyn SP. Clinical and radiographic results of the Total Condylar III and Constrained Condylar total knee arthroplasty. J Arthroplasty. 1996;11:916-922.
32. Leone J, Hanssen A. Management of infection at the site of a total knee arthroplasty. J Bone Joint Surg Am. 2005;87:2335-2348.
33. Lipsett PA. Do we really need laminar flow ventilation in the operating room to prevent surgical site infections? Ann Surg. 2008;248:701-703.
34. Lonner JH, Barrack R, Fitzgerald RH Jr., Hanssen AD, Windsor ER. Infection in total knee arthroplasty. Part I. Classification, prophylaxis, and diagnosis. Am J Orthop (Belle Mead NJ). 1999; 28:530-535.
35. Lonner JH, Barrack R, Fitzgerald RH Jr., Hanssen AD, Windsor ER. Infection in total knee arthroplasty. Part II. Treatment. Am J Orthop (Belle Mead NJ). 1999;28:592-597.
36. Lonner JH, Desai P, Dicesare PE, Steiner G, Zuckerman JD. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am. 1996;78:1553-1558.
37. MacAvoy MC, Ries MD. The ball and socket articulating spacer for infected total knee arthroplasty. J Arthroplasty. 2005;20: 757-762.
38. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250-280.
39. Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am. 2007;89:1227-1231.
40. Mont MA, Waldman BJ, Hungerford DS. Evaluation of preoperative cultures before second-stage reimplantation of a total knee prosthesis complicated by infection: a comparison-group study. J Bone Joint Surg Am. 2000;82:1552-1557.
41. Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. Two stage revision knee arthroplasty for infection with massive bone loss: a technique to achieve spacer stability. Knee. 2011 January 4 [Epub ahead of print].
42. Park SJ, Song EK, Seon JK, Yoon TR, Park GH. Comparison of static and mobile antibiotic-impregnated cement spacers for the treatment of infected total knee arthroplasty. Int Orthop. 2010; 34:1181-1186.
43. Parvizi J, Pawasarat IM,AzzamKA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillinresistant infections. J Arthroplasty. 2010;25(6 Suppl):103-107.
44. Persson C, Baleani M, Guandalini L, Tigani D, Viceconti M. Mechanical effects of the use of vancomycin and meropenem in acrylic bone cement. Acta Orthop. 2006;77:617-621.
45. Peters CL, Erickson JA, Gililland JM. Clinical and radiographic results of 184 consecutive revision total knee arthroplasties placed with modular cementless stems. J Arthroplasty. 2009;24: 48-53.
46. Pietsch M, Hofmann S, Wenisch C. Treatment of deep infection of total knee arthroplasty using a two-stage procedure. Oper Orthop Traumatol. 2006;18:66-87.
47. Pryor F, Messmer PR. The effect of traffic patterns in the OR on surgical site infections. AORN J. 1998;68:649-660.
48. Souillac V, Costes S, Aunoble S, Langlois V, Dutronc H, Chauveaux D. [Evaluation of an articulated spacer for two-stage reimplantation for infected total knee arthroplasty: 28 cases] [in French]. Rev Chir Orthop Reparatrice Appar Mot. 2006;92: 485-489.
49. Su YP, Lee OK, Chen WM, Chen TH. A facile technique to make articulating spacers for infected total knee arthroplasty. J Chin Med Assoc. 2009;72:138-145.
50. US Center for Disease Control and Prevention. Surgical site infection (SSI) event: guidelines and procedures for monitoring SSI. October 2010. Available at: http://www.cdc.gov/nhsn/PDFs/ pscManual/9pscSSIcurrent.pdf. Accessed March 14, 2011.
51. Van Thiel GS, Berend KR, Klein GR, Gordon AC, Lombardi AV, Della Valle CJ. Intraoperative molds to create an articulating spacer for the infected knee arthroplasty. Clin Orthop Relat Res. 2011;469:994-1001.
52. Villanueva-Martinez M, Rios-Luna A, Pereiro J, Fahandez-Saddi H, Villamor A. Hand-made articulating spacers in two-stage revision for infected total knee arthroplasty: good outcome in 30 patients. Acta Orthop. 2008;79:674-682.
53. von Foerster G, Kluber D, Kabler U. [Mid-to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery] [in German]. Orthopade. 1991;20:244-252.
54. Zywiel MG, Daley JA, Delanois RE, Naziri Q, Johnson AJ, Mont MA. Advance pre-operative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop. 2011;35:1001-1006.
55. Zywiel MG, Johnson AJ, Stroh DA, Martin J, Marker DR, Mont MA. Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty. Int Orthop. 2011;35:37-42.